IRCT138903124090N1已完成1 期
A double-blind placebo controlled trial of celecoxibe added to sertralin in patients with moderate to severe depression
ational Iranian Oil Company Health Organization0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •1. Major Depression according to DSM IV and Hamilton Depression Scale(HamD)
- •2. 18 y < age > 50 y
排除标准
- •1. Having psychotic disorders
- •2. Receiving anti-depressant drugs during last month
- •3. Receiving ECT during last two months
- •4. Having thyroid disorder
- •5. Having Cardiovascular disorders
- •6. Pregnancy
- •7. Breast Feeding
- •8. Age <18 y
- •9. Age > 50 y
研究者
相似试验
已完成
2 期
Celecoxib and AutismAutism.Childhood autismIRCT138711091556N2Tehran University of Medical Sciences40
招募中
4 期
Randomised Placebo Controlled Trial of Celecoxib for Acute Burn Inflammation and FeverAcute burn injuryInjuries and Accidents - BurnsACTRN12618000732280Fiona Stanley Hospital150
已完成
2 期
Pentoxifylline in the treatment of autismChildhood autism.Childhood autismIRCT138711161556N7Tehran University of Medical Sciences40
尚未招募
2 期
Treatment Evaluation of Alcohol and MoodAlcoholismDepressionACTRN12606000413527Professor Doug Sellman220
已完成
2 期
Effect of frankincense in treatment of eczemaAtopic dermatitisIRCT20111105008013N5Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center66